This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,489.36, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product.
The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This delivery order has a completion date of December 19, 2024.
The contract is a firm fixed-price, unrestricted award, meaning it does not have a set-aside designation. As a key supplier to the DLA, Dakota Drug, Inc. has established itself as a critical vendor for medical and pharmaceutical procurement, particularly for military medical supply chain operations.
Generated 3/19/25, 9:52 AM